Road Biology Environmental Protection Technology Co., Ltd. (SHA:688156)
China · Delayed Price · Currency is CNY 19.27
+0.52 (2.77%)
At close: Jan 30, 2026
SHA:688156 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 291.62 | 260.19 | 341.44 | 340.34 | 380.34 | 249.9 |
Other Revenue | 17.42 | 17.42 | 9.63 | 1.74 | 1.66 | 0.5 |
| 309.05 | 277.62 | 351.08 | 342.08 | 382 | 250.4 | |
Revenue Growth (YoY) | -9.50% | -20.92% | 2.63% | -10.45% | 52.56% | -17.55% |
Cost of Revenue | 262.58 | 218.66 | 224.19 | 222.82 | 240.75 | 137.93 |
Gross Profit | 46.47 | 58.96 | 126.88 | 119.26 | 141.25 | 112.47 |
Selling, General & Admin | 77.39 | 74.4 | 51.21 | 45.23 | 39.51 | 40.84 |
Research & Development | 19.98 | 19.76 | 13.65 | 13.51 | 15.95 | 11.17 |
Other Operating Expenses | 7.09 | 4.36 | 3.53 | 2.03 | 1.75 | -0.94 |
Operating Expenses | 131.13 | 130.68 | 95.42 | 77.34 | 64.39 | 55.48 |
Operating Income | -84.66 | -71.73 | 31.46 | 41.92 | 76.86 | 56.99 |
Interest Expense | -18.64 | -11.73 | -6.79 | -2.14 | -1.38 | -0.93 |
Interest & Investment Income | 1.05 | 2.84 | 5.48 | 9.25 | 8.19 | 3.08 |
Other Non Operating Income (Expenses) | -1.21 | -1.2 | -0.27 | -0.36 | -0.44 | 0.81 |
EBT Excluding Unusual Items | -103.46 | -81.82 | 29.88 | 48.67 | 83.23 | 59.96 |
Gain (Loss) on Sale of Investments | - | - | 0.03 | 0.21 | 0.1 | - |
Gain (Loss) on Sale of Assets | 1.04 | 0.1 | -0 | 0.54 | 1.09 | 0.04 |
Asset Writedown | 3.01 | -0.07 | -0.15 | - | - | - |
Other Unusual Items | 3.06 | 2.99 | 4.1 | 0.46 | 5.24 | 7.01 |
Pretax Income | -96.35 | -78.8 | 33.85 | 49.88 | 89.67 | 67.01 |
Income Tax Expense | -22.49 | -11.8 | 4.23 | 10.67 | 10.34 | 10.93 |
Earnings From Continuing Operations | -73.85 | -67 | 29.63 | 39.21 | 79.33 | 56.08 |
Minority Interest in Earnings | 4.62 | 10.45 | -2.66 | -13.28 | -3.79 | -8.34 |
Net Income | -69.23 | -56.55 | 26.97 | 25.93 | 75.54 | 47.74 |
Net Income to Common | -69.23 | -56.55 | 26.97 | 25.93 | 75.54 | 47.74 |
Net Income Growth | - | - | 4.02% | -65.68% | 58.23% | 8.37% |
Shares Outstanding (Basic) | 101 | 101 | 96 | 93 | 92 | 75 |
Shares Outstanding (Diluted) | 101 | 101 | 96 | 93 | 92 | 75 |
Shares Change (YoY) | - | 4.84% | 4.02% | 0.51% | 23.49% | 8.37% |
EPS (Basic) | -0.69 | -0.56 | 0.28 | 0.28 | 0.82 | 0.64 |
EPS (Diluted) | -0.69 | -0.56 | 0.28 | 0.28 | 0.82 | 0.64 |
EPS Growth | - | - | - | -65.85% | 28.13% | - |
Free Cash Flow | -137.88 | -287.95 | -341.8 | -145.72 | -14.48 | 11.65 |
Free Cash Flow Per Share | -1.37 | -2.85 | -3.55 | -1.57 | -0.16 | 0.16 |
Dividend Per Share | - | - | 0.050 | 0.100 | 0.300 | 0.200 |
Dividend Growth | - | - | -50.00% | -66.67% | 50.00% | - |
Gross Margin | 15.04% | 21.24% | 36.14% | 34.86% | 36.98% | 44.92% |
Operating Margin | -27.40% | -25.84% | 8.96% | 12.25% | 20.12% | 22.76% |
Profit Margin | -22.40% | -20.37% | 7.68% | 7.58% | 19.78% | 19.07% |
Free Cash Flow Margin | -44.62% | -103.72% | -97.36% | -42.60% | -3.79% | 4.65% |
EBITDA | -30.76 | -25.91 | 66.5 | 68.29 | 101.79 | 81.02 |
EBITDA Margin | -9.95% | -9.33% | 18.94% | 19.96% | 26.65% | 32.36% |
D&A For EBITDA | 53.91 | 45.82 | 35.04 | 26.37 | 24.94 | 24.03 |
EBIT | -84.66 | -71.73 | 31.46 | 41.92 | 76.86 | 56.99 |
EBIT Margin | -27.40% | -25.84% | 8.96% | 12.25% | 20.12% | 22.76% |
Effective Tax Rate | - | - | 12.49% | 21.39% | 11.53% | 16.31% |
Revenue as Reported | 309.05 | 277.62 | 351.08 | 342.08 | 382 | 250.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.